Česky English

+420 511 181 555

info@iccti.eu

Cell therapies

  1. Stem cell therapy
  2. Immunotherapy of cancer

Stem cell therapy

Dear Madam, Dear Sir,

one of the main objectives of the ICCTI Consortium is to enable the access to the latest scientific knowledge in the field of cell therapy to our patients. Research related to stem cell therapies should be brought to the clinical practice without delays in accordance to the recommendation of the European Union, including EU Directive 1394/2007 on innovative treatments.

Please find attached the review of the ICCTI consortium published in scientific journal Stem Cells Dev (2012, 21:2724-52), and describing the use of mesenchymal stem cells in clinical practice.

In cooperation with the clinical institutes associated in the ICCTI consortium, we can offer you the assistance in the treatment of your patients in the following fields of medicine, in which success in stem cell therapies has already been achieved.

Plastic surgery

  • breast enlargement
  • facial enhancements, removal of wrinkles
  • scar healing
  • healing of chronic wounds and ulcers
  • healing of burns

Orthopedics

  • treatment of large-joint arthritis – knees, hips, ankles
  • treatment of herniated spinal discs
  • treatment of arthritis
  • accelerated healing of broken bones
  • healing of injured tendons, ligaments and muscles

Cardiology and diseases of the vascular system

  • myocardial infarction
  • cardiomyopathy
  • critical limb ischemia
  • cerebrovascular ischemia (commonly known as ”stroke”)

Neurology

  • multiple sclerosis
  • cerebrovascular accident (commonly known as ”stroke”)
  • Parkinson’s disease
  • Alzheimer’s disease
  • amyotrophic lateral sclerosis
  • traumatic damage of the brain and spinal cord
  • transverse spinal cord lesion
  • cerebellar ataxia

Eye diseases

  • diabetic retinopathy
  • optic nerve neuritis
  • hypertonic angiopathy
  • age-related macular degeneration

 Urology

  • urinary incontinence
  • erectile dysfunction

Gastroenterology

  • Crohn’s disease
  • liver cirrhosis
  • ulcerative colitis

Pulmonology

  • pulmonary fibrosis
  • chronic obstructive lung disease

Skin diseases

  • dermatomyositis
  • scleroderma
  • psoriasis
  • epidermolysis bullosa

Autoimmune diseases

  • types 1 and 2 diabetes and their complications
  • multiple sclerosis
  • Crohn’s disease
  • rheumatoid arthritis
  • systemic lupus erythematosus

Transplantation

using allogeneic stem cells (from another healthy donor)

  • organ transplants – to prevent rejection
  • hematopoietic cells transplants – to prevent and treat graft-versus-host disease

 

Immunotherapy of cancer

Dear colleagues,

one of the main objectives of the ICCTI Consortium is to enable the access to the latest scientific knowledge in the field of cancer immunotherapy. Research related to cancer immunotherapy should be brought to the clinical practice without delays in accordance to the recommendation of the European Union, including EU Directive 1394/2007 on innovative treatments.

In cooperation with the clinical institutes associated in the ICCTI consortium, we can offer you an assistance in the treatment of your cancer patients with the following diagnoses, in which clinical benefit associated with immunotherapy using anti-cancer vaccination and dendritic cells has already been demonstrated:

  • breast cancer
  • ovarian cancer
  • colorectal cancer
  • renal cell carcinoma
  • prostate cancer
  • melanoma
  • glioblastoma

© 2017 ICCTI. Mezinárodní konsorcium pro buněčnou terapii a imunoterapii | registrační číslo projektu: CZ.1.07/2.3.00/20.0012